🔎 Trials Near Me

Home › Type 2 Diabetes › NCT04024631

Phenotyping Genetic Risk for Type 2 Diabetes

RecruitingHealthy volunteers welcome

Phenotyping Children and Adults With Possible High or Low Genetic Risk for Type 2 Diabetes

Who can join

Ages 10 to 70 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Age 10-70 years
* Prior participant of the UPenn Biobank or Center for Applied Genomics Biobank and agreed to be recontacted for future research.
* Adults with BMI 25kg/m2 or higher, children and adolescents with BMI 85th percentile or higher

Exclusion Criteria:

* prior diagnosis of type 1, type 2, or secondary diabetes
* use of medications that would impact glucose and insulin response such as steroids, metformin or other anti-diabetic medication
* acute illness that may impact insulin and glucose dynamics
* pregnancy
* hypothalamic obesity or related genetic disorder of metabolism
* recent systemic chemotherapy use
* gastrointestinal impairment or surgery that may impact absorption
* anemia
* major organ system illness or any underlying condition requiring regular medication or treatment that could make implementation of the protocol or interpretation of the study results difficult
* inability to comply with study protocol

About the study

This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.

What is being tested

Sponsor: University of Pennsylvania · Participants: 100 · Started: Jun 17, 2019

Contact the study team

Official record on ClinicalTrials.gov — NCT04024631

Locations in the U.S.

PennsylvaniaChildrens Hospital of Philadelphia, Philadelphia (Not yet recruiting)
University of Pennsylvania, Philadelphia

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.